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ABSTRACT
The prevalence of antibodies to Rickettsiae and
other tick-borne microrganisms in the sera of 181
forestry rangers from Friuli-Venezia-Giulia, Italy,
was examined. Seven (3.9%) sera were positive for
Rickettsia conorii and Rickettsia helvetica, as single
or dual infections; four of these sera had been
found previously to be positive for Borrelia burg-
dorferi. Antibodies to Coxiella burnetii were detec-
ted in ﬁve (2.8%) sera, four of which were also
positive for B. burgdorferi. These ﬁndings indicate
that patients in this north-eastern Italian region
with fever subsequent to tick-bite should be
investigated for Rickettsia and Coxiella infections.
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Tick-borne diseases caused by organisms trans-
mitted by the tick Ixodes ricinus, such as Lyme
borreliosis (LB), tick-borne encephalitis (TBE) and
anaplasmosis (formerly ehrlichiosis), have been
detected previously in the Friuli-Venezia-Giulia
(FVG) region of Italy [1–3]. Ixodes spp. ticks have
the potential to transmit several human patho-
gens, including members of the rickettsiales.
Patients with antibodies to Rickettsia helvetica,
and evidence of this microrganism in the ticks,
have been reported in Switzerland, Sweden,
France, Portugal and Japan [4], and also in an
Italian region bordering FVG [5–7]. Infections
concomitant with or consecutive to infections
with Coxiella burnetii and other tick-borne organ-
isms, such as Rickettsia conorii, Rickettsia slovaca,
Rickettsia africae and Francisella tularensis, have
been detected in patients from southern France,
none of whom had a history of Q fever [8]. In a
previous prevalence study carried out among 181
forestry rangers from FVG, Italy, seropositivity
levels of 0.6% for TBE virus, 23.2% for Borrelia
burgdorferi and 0.6% for Anaplasma phagocytophi-
lumwere detected, with 21 of the rangers having a
previous diagnosis of LB [1]. The present study
aimed to extend the previous serosurvey by
investigating the presence of antibodies to Rick-
ettsiae and other tick-borne microorganisms in
the same set of sera, obtained from 181 forestry
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rangers in November 2002. A questionnaire con-
cerning the clinical history of each subject, inclu-
ding possible clinical manifestations of tick-borne
diseases, was completed at the time of collection
of the serum samples. Antibodies to B. burgdorferi
were detected previously in these sera with the C6
ELISA IgG kit (Immunetics, Cambridge, MA,
USA) [1].
The sera were assayed by microimmunoﬂuo-
rescence for IgM, IgG and, sometimes, IgA against
a large panel of antigens, comprising Rickettsia
typhi, C. burnetii, Rickettsia felis, R. helvetica, R.
conorii, Rickettsia israeli, R. africae, Rickettsia sibirica
mongolotimonae, Rickettsia massiliae, R. slovaca,
F. tularensis, Bartonella henselae, and Bartonella
quintana, at the WHO Collaborative Centre for
Rickettsial Research (Marseille, France), as des-
cribed previously [9]. When cross-reacting anti-
bodies with a titre > 1:64 prevented identiﬁcation
of the infecting agent, cross-adsorption was per-
formed using either R. helvetica or R. conori
antigens. Positive sera were assayed further by
western blot IgG as described previously [8].
All sera were negative for B. henselae, B.
quintana and F. tularensis, but seven (3.9%) sera
were positive for R. conorii and R. helvetica by
microimmunoﬂuorescence (IgG titres > 1 ⁄ 64), and
four of these sera cross-reacted with different
rickettsial antigens. Western blot revealed a band-
pattern typical of R. helvetica for serum 1. Three
sera were cross-adsorbed with either R. conorii or
R. helvetica antigens, and were assayed further
by western blot to identify the species-speciﬁc
antibodies. Serum 2 maintained reactivity with
R. conorii following adsorption with R. helvetica,
while serum 3 showed a residual band with
R. helvetica following adsorption with R. conorii;
this indicates that serum 2 had antibodies to
R. conorii and that serum 3 had antibodies to
R. helvetica. Serum 4 was positive for both rick-
ettsial antigens with an IgG titre of 1 ⁄ 1024 and an
IgM titre of 1 ⁄ 128; a dual infection with R. helvetica
and R. conorii has been shown with a higher
absorption. Since no history of Boutonneuse Fever
or other Spotted Fever group rickettsial diseases
had been reported by the forestry rangers, these
antibodies were considered to be elicited by
repeated or concomitant asymptomatic infections.
Four of the seven sera had been found previously
to be positive for B. burgdorferi [1].
Five (2.8%) sera were positive for C. burnetii.
Antibody titres were high, and both phases of
C. burnetii were identiﬁed by microimmunoﬂuo-
rescence (Table 1). On the basis of antibody titres
(IgG and IgM) obtained during phase I and ⁄ or II,
the patterns of sera 1, 2, 3 and 5 indicated chronic
infections, while the pattern of serum 4 indicated
an acute infection. No clinical history of Q fever,
particularly symptoms associated with atypical
pneumonia, hepatitis or endocarditis, was ob-
tained for these ﬁve forestry rangers, four of
whom had been found previously to be seropos-
itive for B. burgdorferi [1]. Interestingly, of the 42
forestry rangers seropositive for B. burgdorferi,
four (9.5%) were also positive for C. burnetii,
whereas only one (0.7%) of 139 forestry rangers
seronegative for B. burgdorferi was positive for
C. burnetii (chi-square test, p < 0.01).
More than 40 tick species, including Ixodes,
Rhipicephalus and Amblyomma, are infected natur-
ally with C. burnetii [10]. However, arthropod-
borne transmission of the Q fever agent in
humans is reported rarely. According to the
present ﬁndings, the signiﬁcant association be-
tween C. burnetii and B. burgdorferi seropositivity,
undoubtedly transmitted through I. ricinus bites,
suggests that this tick may also transmit C. burnetii
in some areas of FVG. Q fever has been detected
in almost every country, but its incidence is
probably underestimated because of poor surveil-
lance of the disease [10]. Indeed, only a few
sporadic cases have been notiﬁed in Italy since
1970 [11]. More recently, two outbreaks of Q fever
occurred in Vicenza and Como, northern Italy,
involving 54 and 133 patients, respectively [12,13].
In both outbreaks, indirect exposure to migrating
ﬂocks of sheep turned out to be the only risk-
factor for acquisition of C. burnetii infection. This
infection is usually asymptomatic or manifests as
a mild ﬂu-like illness in humans. Among symp-
tomatic patients, most experience a self-limited
febrile illness, atypical pneumonia or hepatitis,
Table 1. Serological ﬁndings for Borellia burgdorferi among




C. burnetii, phase I
IgG ⁄ IgM ⁄ IgA
C. burnetii, phase II
IgG ⁄ IgM ⁄ IgA
B. burgdorferi
(C6 ELISA)b
1 6400 ⁄ 0 ⁄ 100 3200 ⁄ 0 ⁄ 50 + (1121)
2 3200 ⁄ 100 ⁄ 1600 1600 ⁄ 50 ⁄ 800 + (221)
3 3200 ⁄ 200 ⁄ 400 1600 ⁄ 100 ⁄ 200 + (202)
4 100 ⁄ 200 ⁄ 0 50 ⁄ 100 ⁄ 0 –
5 1600 ⁄ 50 ⁄ 0 800 ⁄ 25 ⁄ 0 + (415)
aTitres obtained by microimmunoﬂuorescence.
bOD values (cut-off value = 183).
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with < 1% suffering from chronic Q fever, includ-
ing endocarditis [10]. Thus, C. burnetii infection is
usually not detected unless serological testing is
performed.
To our knowledge, this is the ﬁrst report to
demonstrate the presence of R. helvetica antibod-
ies, as well as co-infection with R. conorii, in FVG.
The ﬁndings suggest that C. burnetii and other
rickettsial tick-transmitted agents should be con-
sidered in the differential diagnosis of febrile
patients with a recent history of tick bite in this
north-eastern region of Italy.
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